NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 181 filers reported holding NOVAVAX INC in Q1 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $46,000 | -67.6% | 82,929 | +7.8% | 0.00% | -62.5% |
| Q4 2018 | $142,000 | +69.0% | 76,918 | +72.1% | 0.01% | +60.0% |
| Q3 2018 | $84,000 | -53.8% | 44,690 | -67.2% | 0.01% | -37.5% |
| Q2 2018 | $182,000 | -87.0% | 136,177 | -87.9% | 0.01% | -89.2% |
| Q4 2017 | $1,395,000 | +12581.8% | 1,124,842 | +11061.4% | 0.07% | +7300.0% |
| Q3 2017 | $11,000 | -90.8% | 10,078 | -28.8% | 0.00% | -94.1% |
| Q4 2015 | $119,000 | -72.2% | 14,151 | -63.1% | 0.02% | -55.3% |
| Q2 2015 | $428,000 | – | 38,398 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |